Actinium Pharmaceuticals (ATNM) Non Operating Income (2010 - 2026)
Actinium Pharmaceuticals' Non Operating Income came in at $336,000 for Q2 2026, down 46.2% from $625,000 a year earlier and down 11.8% from the prior quarter.
Powered by 
Analysis
Actinium Pharmaceuticals (ATNM) Non Operating Income (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Actinium Pharmaceuticals reported Non Operating Income of $1.75 million, down 45.4% year-over-year; for FY2025, it was $2.36 million, down 39.1% from FY2024.
- Non Operating Income carries a five-year compound annual growth rate of 67.7% (FY2020 to FY2025).
- Going back by year, Non Operating Income was $3.88 million in FY2024 (+25.0%), $3.1 million in FY2023 (+185.4%), $1.09 million in FY2022 (+472.1%) and $190,000 in FY2021 (+6.7%).
- The Q2 2026 figure represents the lowest quarterly Non Operating Income since Q3 2022.
- Year-over-year, Non Operating Income has declined for eight consecutive quarters, with an average decline of 33.5% over the last eight quarters.
- The fastest year-over-year change in Non Operating Income over five years came in Q3 2022 (growth of 606.5%), and the weakest in Q2 2026 (a decline of 46.2%).
- Business Quant data shows ATNM's Non Operating Income at $381,000 (Q1 2026), $474,000 (Q4 2025) and $561,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Actinium Pharmaceuticals | 36.16 Mn | 36.16 Mn | - | 336,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 336,000.00 |
| Mar 31, 2026 | 381,000.00 |
| Dec 31, 2025 | 474,000.00 |
| Sep 30, 2025 | 561,000.00 |
| Jun 30, 2025 | 625,000.00 |
| Mar 31, 2025 | 700,000.00 |
| Dec 31, 2024 | 853,000.00 |
| Sep 30, 2024 | 1.03 Mn |
| Jun 30, 2024 | 1.07 Mn |
| Mar 31, 2024 | 927,000.00 |
| Dec 31, 2023 | 1.02 Mn |
| Sep 30, 2023 | 1.08 Mn |
| Jun 30, 2023 | 461,000.00 |
| Mar 31, 2023 | 547,000.00 |
| Dec 31, 2022 | 644,000.00 |
| Sep 30, 2022 | 325,000.00 |
| Jun 30, 2022 | 83,000.00 |
| Mar 31, 2022 | 35,000.00 |
| Dec 31, 2021 | 38,000.00 |
| Sep 30, 2021 | 46,000.00 |
API Access
Actinium Pharmaceuticals Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=ATNM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "ATNM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=ATNM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();